Hawaii 2023 Regular Session

Hawaii Senate Bill SCR133

Introduced
3/10/23  

Caption

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

Impact

If enacted, SCR133 would lead to the formation of a working group tasked with evaluating federal, state, and local laws concerning psilocybin. It aims to assess existing medical and scientific research about psilocybin's safety and efficacy in treating significant mental health disorders. The working group would also investigate jurisdictions where psilocybin is legally used and develop a strategic plan for its therapeutic availability to adults aged twenty-one and over. The group is expected to report its findings and propose legislation to the legislature prior to the 2024 session, contributing to informed discussions around mental health care reforms in the state.

Summary

SCR133, introduced in the State of Hawaii's Thirty-Second Legislature in 2023, seeks to address the growing mental health crisis by requesting the Department of Health to establish a Therapeutic Psilocybin Working Group. The resolution highlights the urgency of mental health issues exacerbated by a shortage of professionals and suggests that psilocybin, which has shown effectiveness in treating various conditions such as PTSD, depression, and anxiety, could be a potential solution. This initiative aligns with the recent recognition by the FDA of psilocybin as a 'breakthrough therapy' for treatment-resistant depression.

Contention

Notable points of contention may arise concerning the regulation and accessibility of psilocybin, especially considering its current legal status and societal perceptions. Supporters advocate for its potential to provide innovative treatment options amid prevailing mental health challenges, while opponents may express concerns about the implications of normalizing a psychedelic substance within therapeutic environments. The establishment of such a working group may lead to debates regarding regulation, safety protocols, and ethical considerations for psilocybin's medicinal use.

Companion Bills

HI SR153

Same As Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI HCR202

Same As Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

Previously Filed As

HI HB1337

Relating To Psilocybin.

HI SB1454

Relating To Psilocybin.

HI SCR39

Requesting The Department Of Human Services To Convene A Baby Bonds Working Group.

HI HCR44

Requesting The Department Of Human Services To Convene A Baby Bonds Working Group.

HI SCR132

Requesting The Office Of The Governor To Convene A Working Group To Plan For The Remediation Of Perfluoroalkyl And Polyfluoroalkyl Substances (pfas) In The State.

HI SR28

Requesting The Department Of Human Services To Convene A Baby Bonds Working Group.

HI HR33

Requesting The Department Of Human Services To Convene A Baby Bonds Working Group.

HI SCR65

Urging The Department Of Health To Convene An Informal Working Group To Assess The Registration And Monitoring Of All Group Living Facilities As Described In Section 46-4(d), Hawaii Revised Statutes, Including Clean And Sober Homes.

HI SCR15

Requesting The Department Of Health's State Health Planning And Development Agency To Convene A Health Data Sharing Working Group To Accelerate And Expand The Sharing Of Real Time Health Information Among Health Care Entities And Government Agencies In The State.

HI SCR194

Requesting The Department Of Human Resource Development To Convene A Working Group To Help State Department Managers Foster Thriving Work Environments.

Similar Bills

HI SR153

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI HR206

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI HCR202

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group.

HI SR88

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Longterm Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

HI SB3160

Relating To Psilocybin.

HI HB2400

Relating To Psilocybin.

HI SCR100

Requesting The Department Of Health To Convene A Therapeutic Psilocybin Working Group To Examine The Medicinal And Therapeutic Effects Of Psilocybin And Develop A Long-term Strategic Plan, Should Food And Drug Administration Approval For Medical Use Be Obtained, To Enable The Availability Of Therapeutic Psilocybin Or Psilocybin-based Products That Are Safe, Accessible, And Affordable For Adults Twenty-one Years Of Age Or Older.

HI SB1454

Relating To Psilocybin.